KAYO-1732

N/A

Report date: 2025/04/14 16:30:18
NMEFirst In Class

Base Information

Drug NameKAYO-1732
Drug Alias NameKAYO-1732KAYO1732
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldehyde Dehydrogenase 1 Family Member A3 inhibitors
TargetsAldehyde Dehydrogenase 1 Family Member A3
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKayoThera Inc
China Registration ClassN/A

Develop Information

Active CompaniesKayoThera Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A